ANVS
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Annovis completed enrollment in the pivotal Phase 3 trial of buntanetap for early Alzheimer's diseaseJul 8, 2026
- Annovis published Phase 2/3 Alzheimer's trial results in Nature PortfolioApr 28, 2026
- Annovis secured a U.S. patent for buntanetap for prevention and treatment of neurological injuries from brain infectionsApr 2, 2026
- Annovis received DSMB approval to advance the pivotal Phase 3 trial of buntanetap in Alzheimer’s diseaseFeb 12, 2026
- Annovis announced FDA meeting to discuss Parkinson's disease dementia program; reaffirmed FDA alignment on pivotal Phase 3 Alzheimer's disease studyNov 19, 2025